pharma · Amyotrophic Lateral Sclerosis · Pharmacokinetics · NRSN
NeuroSense Therapeutics
News and analysis for NeuroSense Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.
Cambridge, USA HQ
2017 Founded
30 Employees
Public company Type
NRSN · NYSE Ticker
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2017
- Employees
- 30
- Programs
- 6
- Drugs
- 6
- Patents
- 2
News & analysis
NovaPharmaNews articles mentioning NeuroSense Therapeutics — regulatory, clinical, and market coverage.
News and analysis for NeuroSense Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.